These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37743681)

  • 21. Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 35-37 weeks.
    Fadigas C; Guerra L; Garcia-Tizon Larroca S; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jun; 45(6):715-21. PubMed ID: 25780898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks.
    Bakalis S; Stoilov B; Akolekar R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jun; 45(6):707-14. PubMed ID: 25585604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimated fetal weight at mid-gestation in prediction of pre-eclampsia in singleton pregnancy.
    Frei L; Wright A; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Mar; 59(3):335-341. PubMed ID: 34860455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 19-24 weeks.
    Lesmes C; Gallo DM; Saiid Y; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Sep; 46(3):332-40. PubMed ID: 25810352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of fetal growth trajectory from 20 weeks of gestation onwards for severe adverse perinatal outcome in low-risk population: secondary analysis of IRIS study.
    Kamphof HD; van Roekel M; Henrichs J; de Vreede H; Verhoeven CJ; Franx A; de Jonge A; Ganzevoort W; Gordijn SJ
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):796-804. PubMed ID: 37204332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks' gestation.
    Papastefanou I; Nowacka U; Syngelaki A; Mansukhani T; Karamanis G; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Nov; 225(5):530.e1-530.e19. PubMed ID: 33901487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound prediction of adverse perinatal outcome at diagnosis of late-onset fetal growth restriction.
    Dall'Asta A; Stampalija T; Mecacci F; Minopoli M; Schera GBL; Cagninelli G; Ottaviani C; Fantasia I; Barbieri M; Lisi F; Simeone S; Ghi T; Frusca T
    Ultrasound Obstet Gynecol; 2022 Mar; 59(3):342-349. PubMed ID: 34159652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the RCOG guideline for the prediction of neonates that are small for gestational age and comparison with the competing risks model.
    Papastefanou I; Nowacka U; Buerger O; Akolekar R; Wright D; Nicolaides KH
    BJOG; 2021 Dec; 128(13):2110-2115. PubMed ID: 34139043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19-24 weeks.
    Poon LC; Lesmes C; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):437-45. PubMed ID: 25988293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Lolos M; Anampousi K; Mamalis M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):392-400. PubMed ID: 32936500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.
    Miranda J; Rodriguez-Lopez M; Triunfo S; Sairanen M; Kouru H; Parra-Saavedra M; Crovetto F; Figueras F; Crispi F; Gratacós E
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):603-611. PubMed ID: 28004439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-trimester and combined first- and second-trimester prediction of small-for-gestational age and late fetal growth restriction.
    Sotiriadis A; Figueras F; Eleftheriades M; Papaioannou GK; Chorozoglou G; Dinas K; Papantoniou N
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):55-61. PubMed ID: 29573501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of small-for-gestational-age neonate by third-trimester fetal biometry and impact of ultrasound-delivery interval.
    Reboul Q; Delabaere A; Luo ZC; Nuyt AM; Wu Y; Chauleur C; Fraser W; Audibert F
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):372-378. PubMed ID: 27153518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse perinatal outcomes are strongly associated with degree of abnormality in uterine artery Doppler pulsatility index.
    Dockree S; Aye C; Ioannou C; Cavallaro A; Black R; Impey L;
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):504-512. PubMed ID: 38669595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction.
    Mascherpa M; Pegoire C; Meroni A; Minopoli M; Thilaganathan B; Frick A; Bhide A
    Ultrasound Obstet Gynecol; 2024 May; 63(5):605-612. PubMed ID: 38145554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction.
    Roberts LA; Ling HZ; Poon LC; Nicolaides KH; Kametas NA
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):507-514. PubMed ID: 29607557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-eclampsia screening in Denmark (PRESIDE): national validation study.
    Riishede I; Rode L; Sperling L; Overgaard M; Ravn JD; Sandager P; Skov H; Wagner SR; Nørgaard P; Clausen TD; Jensen CAJ; Pihl K; Jørgensen FS; Munk JK; Zingenberg HJ; Pedersen NG; Andersen MR; Wright A; Wright D; Tabor A; Ekelund CK
    Ultrasound Obstet Gynecol; 2023 Jun; 61(6):682-690. PubMed ID: 36840981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.